Woman's World on MSN
Meet the Addyi pill, a.k.a. pink Viagra: Why the FDA's new 2025 approval is a ‘historic first' for women over 50
Viagra, the little blue pill, has been a household name for more than a generation. And now women's sexual health is finally ...
The FDA expanded its approval of Addyi to treat low libido in postmenopausal women up to age 65. The approval will open up ...
HSDD affects 40%-55% of postmenopausal women, often due to hormonal changes, impacting sexual desire and quality of life.
Amaze Lab on MSN
FDA approves first ever female libido pill—with one catch
The U.S. Food and Drug Administration recently expanded approval of Addyi, a daily pill for low sex drive, to postmenopausal ...
Up until now, women who’d surpassed menopause and were dealing with frustratingly low libido—a.k.a. hypoactive sexual desire ...
In the often unspoken world of female sexual health, a revolution has started, and it began with the introduction of a unique medication called Addyi. Traditionally, when we think of sexual ...
The FDA approved Addyi (flibanserin), a libido-enhancing drug, in postmenopausal women under the age of 65. Experts explain ...
Addyi is the first and only FDA-approved, hormone-free pill clinically proven to treat low sexual desire in women RALEIGH, N.C., July 24, 2025 /PRNewswire/ -- Sprout Pharmaceuticals today announced ...
IRVINE, CA – July 5, 2023 – The Ad Firm is thrilled to announce the publication of an abstract by Sprout Pharmaceuticals, showcasing the remarkable effects of Addyi (flibanserin) on low libido among ...
Addyi, the first FDA-approved medication for low libido in women under 65, offers a new treatment option. Learn about its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback